BlackRock »

Urogen Pharma shares owned by BlackRock

Quarter-by-quarter ownership of Urogen Pharma (URGN) shares owned by BlackRock from 13F filings

Historical chart of BlackRock investment in Urogen Pharma

Tip: Access up to 7 years of quarterly data

All positions including Urogen Pharma held by BlackRock consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Urogen Pharma by BlackRock

Quarter filed Position value Share count Share price at filing
2024-12-31 $26M 2.5M 10.65
2024-09-30 $32M 2.5M 12.70

More positions owned by BlackRock

Apple (AAPL)
NVIDIA Corporation (NVDA)
Microsoft Corporation (MSFT)
Amazon (AMZN)
Meta Platforms Cl A (META)
Broadcom (AVGO)
Tesla Motors (TSLA)
Alphabet Cap Stk Cl A (GOOGL)
Alphabet Cap Stk Cl C (GOOG)
Eli Lilly & Co. (LLY)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
JPMorgan Chase & Co. (JPM)
Visa Com Cl A (V)
Ishares Tr Core S&p500 Etf (IVV)
Mastercard Incorporated Cl A (MA)

View all positions for BlackRock

Top funds holding Urogen Pharma

Rtw Investments
Adage Capital Partners GP
BlackRock
Menora Mivtachim Holdings
Toronto-Dominion Bank
Ubs Global Asset Management Americas
Nantahala Capital Management
Leucadia National Corporation
UBS Group
Silverarc Capital Management
Rosalind Advisors
State Street Corporation
Morgan Stanley
Migdal Insurance & Financial Holdings
Millennium Management

View all funds holding Urogen Pharma